Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer

OBJECTIVE: In this study, we evaluated the toxicity and clinical efficacy of nivolumab, a programmed cell death protein 1 (PD-1) inhibitor, on patients with platinum resistant ovarian cancer. METHODS: Every second week, 18 patients with platinum resistance ovarian cancer received nivolumab until dis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gynecol Oncol
Autors principals: Normann, Marius C., Türzer, Martin, Diep, Lien My, Oldenburg, Jan, Gajdzik, Beata, Solheim, Olesya, Rud, Erik
Format: Artigo
Idioma:Inglês
Publicat: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543107/
https://ncbi.nlm.nih.gov/pubmed/31074244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2019.30.e56
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars